Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2013 May 1;56(5):399–405. doi: 10.1007/s11427-013-4478-0

Immunosenescence and age-related viral diseases

YongChao Ma 1, Min Fang 1,✉
PMCID: PMC7089158  PMID: 23633071

Abstract

Immunosenescence is described as a decline in the normal functioning of the immune system associated with physiologic ageing. Immunosenescence contributes to reduced efficacy to vaccination and increased susceptibility to infectious diseases in the elderly. Extensive studies of laboratory animal models of ageing or donor lymphocyte analysis have identified changes in immunity caused by the ageing process. Most of these studies have identified phenotypic and functional changes in innate and adaptive immunity. However, it is unclear which of these defects are critical for impaired immune defense against infection. This review describes the changes that occur in innate and adaptive immunity with ageing and some age-related viral diseases where defects in a key component of immunity contribute to the high mortality rate in mouse models of ageing.

Keywords: immunosenescence, physiologic ageing, infectious disease

Footnotes

This article is published with open access at Springerlink.com

References

  • 1.Aspinall R, Del Giudice G, Effros R B, et al. Challenges for vaccination in the elderly. Immun Ageing. 2007;4:9. doi: 10.1186/1742-4933-4-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ongradi J, Stercz B, Kovesdi V, et al. Immunosenescence and vaccination of the elderly II. New strategies to restore age-related immune impairment. Acta Microbiol Immunol Hung. 2009;56:301–312. doi: 10.1556/AMicr.56.2009.4.1. [DOI] [PubMed] [Google Scholar]
  • 3.Andrews N P, Fujii H, Goronzy J J, et al. Telomeres and immunological diseases of aging. Gerontology. 2010;56:390–403. doi: 10.1159/000268620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bernstein E, Kaye D, Abrutyn E, et al. Immune response to influenza vaccination in a large healthy elderly population. Vaccine. 1999;17:82–94. doi: 10.1016/S0264-410X(98)00117-0. [DOI] [PubMed] [Google Scholar]
  • 5.Weinberger B, Herndler-Brandstetter D, Schwanninger A, et al. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis. 2008;46:1078–1084. doi: 10.1086/529197. [DOI] [PubMed] [Google Scholar]
  • 6.Moon J J, Chu H H, Pepper M, et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity. 2007;27:203–213. doi: 10.1016/j.immuni.2007.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Naylor K, Li G, Vallejo A N, et al. The influence of age on T cell generation and TCR diversity. J Immunol. 2005;174:7446–7452. doi: 10.4049/jimmunol.174.11.7446. [DOI] [PubMed] [Google Scholar]
  • 8.Leng S X. Role of chronic cytomegalovirus infection in T-cell immunosenescence and frailty: more questions than answers. J Am Geriatr Soc. 2011;59:2363–2365. doi: 10.1111/j.1532-5415.2011.03815.x. [DOI] [PubMed] [Google Scholar]
  • 9.Voehringer D, Koschella M, Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1) Blood. 2002;100:3698–3702. doi: 10.1182/blood-2002-02-0657. [DOI] [PubMed] [Google Scholar]
  • 10.LeMaoult J, Messaoudi I, Manavalan J S, et al. Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J Immunol. 2000;165:2367–2373. doi: 10.4049/jimmunol.165.5.2367. [DOI] [PubMed] [Google Scholar]
  • 11.Yager E J, Ahmed M, Lanzer K, et al. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med. 2008;205:711–723. doi: 10.1084/jem.20071140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pawelec G, Akbar A, Beverley P, et al. Immunosenescence and Cytomegalovirus: where do we stand after a decade? Immun Ageing. 2010;7:13. doi: 10.1186/1742-4933-7-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pawelec G, Akbar A, Caruso C, et al. Is immunosenescence infectious? Trends Immunol. 2004;25:406–410. doi: 10.1016/j.it.2004.05.006. [DOI] [PubMed] [Google Scholar]
  • 14.Vasto S, Colonna-Romano G, Larbi A, et al. Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing. 2007;4:2. doi: 10.1186/1742-4933-4-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Barrett L, Fowke K R, Grant M D. Cytomegalovirus, aging, and HIV: a perfect storm. AIDS Rev. 2012;14:159–167. [PubMed] [Google Scholar]
  • 16.Akbar A N, Fletcher J M. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol. 2005;17:480–485. doi: 10.1016/j.coi.2005.07.019. [DOI] [PubMed] [Google Scholar]
  • 17.Almanzar G, Schwaiger S, Jenewein B, et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol. 2005;79:3675–3683. doi: 10.1128/JVI.79.6.3675-3683.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Khan N, Hislop A, Gudgeon N, et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol. 2004;173:7481–7489. doi: 10.4049/jimmunol.173.12.7481. [DOI] [PubMed] [Google Scholar]
  • 19.Zhong S, Zheng H Y, Suzuki M, et al. Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J Clin Microbiol. 2007;45:193–198. doi: 10.1128/JCM.01645-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Decman V, Laidlaw B J, Dimenna L J, et al. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection. J Immunol. 2010;184:5151–5159. doi: 10.4049/jimmunol.0902063. [DOI] [PubMed] [Google Scholar]
  • 21.Naumova E, Ivanova M, Pawelec G. Immunogenetics of ageing. Int J Immunogenet. 2011;38:373–381. doi: 10.1111/j.1744-313X.2011.01022.x. [DOI] [PubMed] [Google Scholar]
  • 22.Vallejo A N. Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged. Immunol Res. 2006;36:221–228. doi: 10.1385/IR:36:1:221. [DOI] [PubMed] [Google Scholar]
  • 23.Aw D, Palmer D B. The origin and implication of thymic involution. Aging Dis. 2011;2:437–443. [PMC free article] [PubMed] [Google Scholar]
  • 24.Goronzy J J, Weyand C M. T cell development and receptor diversity during aging. Curr Opin Immunol. 2005;17:468–475. doi: 10.1016/j.coi.2005.07.020. [DOI] [PubMed] [Google Scholar]
  • 25.Effros R B, Dagarag M, Spaulding C, et al. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005;205:147–157. doi: 10.1111/j.0105-2896.2005.00259.x. [DOI] [PubMed] [Google Scholar]
  • 26.Frasca D, Diaz A, Romero M, et al. Age effects on B cells and humoral immunity in humans. Ageing Res Rev. 2011;10:330–335. doi: 10.1016/j.arr.2010.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Frasca D, Blomberg B B. Effects of aging on B cell function. Curr Opin Immunol. 2009;21:425–430. doi: 10.1016/j.coi.2009.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Paganelli R, Quinti I, Fagiolo U, et al. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol. 1992;90:351–354. doi: 10.1111/j.1365-2249.1992.tb07954.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mehr R, Melamed D. Reversing B cell aging. Aging. 2011;3:438–443. doi: 10.18632/aging.100313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.LeMaoult J, Szabo P, Weksler M E. Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev. 1997;160:115–126. doi: 10.1111/j.1600-065X.1997.tb01032.x. [DOI] [PubMed] [Google Scholar]
  • 31.Shi Y, Yamazaki T, Okubo Y, et al. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol. 2005;175:3262–3267. doi: 10.4049/jimmunol.175.5.3262. [DOI] [PubMed] [Google Scholar]
  • 32.Frasca D, Riley R L, Blomberg B B. Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin Immunol. 2005;17:378–384. doi: 10.1016/j.smim.2005.05.005. [DOI] [PubMed] [Google Scholar]
  • 33.Van der Put E, Sherwood E M, Blomberg B B, et al. Aged mice exhibit distinct B cell precursor phenotypes differing in activation, proliferation and apoptosis. Exp Gerontol. 2003;38:1137–1147. doi: 10.1016/j.exger.2003.07.003. [DOI] [PubMed] [Google Scholar]
  • 34.LeBien T W, Tedder T F. B lymphocytes: how they develop and function. Blood. 2008;112:1570–1580. doi: 10.1182/blood-2008-02-078071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bernasconi N L, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298:2199–2202. doi: 10.1126/science.1076071. [DOI] [PubMed] [Google Scholar]
  • 36.Seifert M, Kuppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med. 2009;206:2659–2669. doi: 10.1084/jem.20091087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Macallan D C, Wallace D L, Zhang Y, et al. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood. 2005;105:3633–3640. doi: 10.1182/blood-2004-09-3740. [DOI] [PubMed] [Google Scholar]
  • 38.Frasca D, Diaz A, Romero M, et al. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine. 2010;28:8077–8084. doi: 10.1016/j.vaccine.2010.10.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Johnson S A, Cambier J C. Ageing, autoimmunity and arthritis: senescence of the B cell compartment-implications for humoral immunity. Arthritis Res Ther. 2004;6:131–139. doi: 10.1186/ar1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lazuardi L, Jenewein B, Wolf A M, et al. Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology. 2005;114:37–43. doi: 10.1111/j.1365-2567.2004.02006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ginaldi L, De Martinis M, D’Ostilio A, et al. The immune system in the elderly: III. Innate immunity. Immunol Res. 1999;20:117–126. doi: 10.1007/BF02786468. [DOI] [PubMed] [Google Scholar]
  • 42.Panda A, Arjona A, Sapey E, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009;30:325–333. doi: 10.1016/j.it.2009.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Cooper M A, Fehniger T A, Caligiuri M A. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633–640. doi: 10.1016/S1471-4906(01)02060-9. [DOI] [PubMed] [Google Scholar]
  • 44.Lanier L L. NK cell recognition. Annu Rev Immunol. 2005;23:225–274. doi: 10.1146/annurev.immunol.23.021704.115526. [DOI] [PubMed] [Google Scholar]
  • 45.Robertson M J, Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 1990;76:2421–2438. [PubMed] [Google Scholar]
  • 46.Lanier L L, Testi R, Bindl J, et al. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989;169:2233–2238. doi: 10.1084/jem.169.6.2233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Campbell J J, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001;166:6477–6482. doi: 10.4049/jimmunol.166.11.6477. [DOI] [PubMed] [Google Scholar]
  • 48.Nagler A, Lanier L L, Phillips J H. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J Exp Med. 1990;171:1527–1533. doi: 10.1084/jem.171.5.1527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Robertson M J, Soiffer R J, Wolf S F, et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med. 1992;175:779–788. doi: 10.1084/jem.175.3.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Sansoni P, Cossarizza A, Brianti V, et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 1993;82:2767–2773. [PubMed] [Google Scholar]
  • 51.Thompson J S, Wekstein D R, Rhoades J L, et al. The immune status of healthy centenarians. J Am Geriatr Soc. 1984;32:274–281. doi: 10.1111/j.1532-5415.1984.tb02021.x. [DOI] [PubMed] [Google Scholar]
  • 52.Burkle A, Caselli G, Franceschi C, et al. Pathophysiology of ageing, longevity and age related diseases. Immun Ageing. 2007;4:4. doi: 10.1186/1742-4933-4-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Miyaji C, Watanabe H, Toma H, et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol. 2000;61:908–916. doi: 10.1016/S0198-8859(00)00153-1. [DOI] [PubMed] [Google Scholar]
  • 54.Vitale M, Zamai L, Neri L M, et al. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell Immunol. 1992;145:1–10. doi: 10.1016/0008-8749(92)90307-B. [DOI] [PubMed] [Google Scholar]
  • 55.Solana R, Tarazona R, Gayoso I, et al. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24:331–341. doi: 10.1016/j.smim.2012.04.008. [DOI] [PubMed] [Google Scholar]
  • 56.Borrego F, Alonso M C, Galiani M D, et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol. 1999;34:253–265. doi: 10.1016/S0531-5565(98)00076-X. [DOI] [PubMed] [Google Scholar]
  • 57.Ogata K, Yokose N, Tamura H, et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol. 1997;84:269–275. doi: 10.1006/clin.1997.4401. [DOI] [PubMed] [Google Scholar]
  • 58.Simpson R J, Lowder T W, Spielmann G, et al. Exercise and the aging immune system. Ageing Res Rev. 2012;11:404–420. doi: 10.1016/j.arr.2012.03.003. [DOI] [PubMed] [Google Scholar]
  • 59.Farag S S, Fehniger T, Ruggeri L, et al. Natural killer cells: biology and application in stem-cell transplantation. Cytotherapy. 2002;4:445–446. doi: 10.1080/146532402320776134. [DOI] [PubMed] [Google Scholar]
  • 60.Sconocchia G, Lau M, Provenzano M, et al. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions. Blood. 2005;106:3666–3672. doi: 10.1182/blood-2005-02-0479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Verheyden S, Ferrone S, Mulder A, et al. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells. Cancer Immunol Immunother. 2009;58:855–865. doi: 10.1007/s00262-008-0601-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Lutz C T, Moore M B, Bradley S, et al. Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev. 2005;126:722–731. doi: 10.1016/j.mad.2005.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Lemster B H, Michel J J, Montag D T, et al. Induction of CD56 and TCR-independent activation of T cells with aging. J Immunol. 2008;180:1979–1990. doi: 10.4049/jimmunol.180.3.1979. [DOI] [PubMed] [Google Scholar]
  • 64.Abedin S, Michel J J, Lemster B, et al. Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp Gerontol. 2005;40:537–548. doi: 10.1016/j.exger.2005.04.012. [DOI] [PubMed] [Google Scholar]
  • 65.Almeida-Oliveira A, Smith-Carvalho M, Porto L C, et al. Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol. 2011;72:319–329. doi: 10.1016/j.humimm.2011.01.009. [DOI] [PubMed] [Google Scholar]
  • 66.Le Garff-Tavernier M, Beziat V, Decocq J, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging cell. 2010;9:527–535. doi: 10.1111/j.1474-9726.2010.00584.x. [DOI] [PubMed] [Google Scholar]
  • 67.Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine. 2000;18:1613–1620. doi: 10.1016/S0264-410X(99)00495-8. [DOI] [PubMed] [Google Scholar]
  • 68.Krishnaraj R, Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL 2-induced interferon gamma secretion. Immunol Lett. 1996;50:59–63. doi: 10.1016/0165-2478(96)02519-9. [DOI] [PubMed] [Google Scholar]
  • 69.Mariani E, Pulsatelli L, Neri S, et al. RANTES and MIP-1alpha production by T lymphocytes, monocytes and NK cells from nonagenarian subjects. Exp Gerontol. 2002;37:219–226. doi: 10.1016/S0531-5565(01)00187-5. [DOI] [PubMed] [Google Scholar]
  • 70.Mocchegiani E, Giacconi R, Cipriano C, et al. The variations during the circadian cycle of liver CD1d-unrestricted NK1.1+TCR gamma/ delta+ cells lead to successful ageing. Role of metallothionein/ IL-6/gp130/PARP-1 interplay in very old mice. Exp Gerontol. 2004;39:775–788. doi: 10.1016/j.exger.2004.01.014. [DOI] [PubMed] [Google Scholar]
  • 71.Kaszubowska L, Kaczor J J, Hak L, et al. Sensitivity of natural killer cells to activation in the process of ageing is related to the oxidative and inflammatory status of the elderly. J Physiol Pharmacol. 2011;62:101–109. [PubMed] [Google Scholar]
  • 72.Mocchegiani E, Muzzioli M, Giacconi R, et al. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev. 2003;124:459–468. doi: 10.1016/S0047-6374(03)00023-X. [DOI] [PubMed] [Google Scholar]
  • 73.Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254. doi: 10.1111/j.1749-6632.2000.tb06651.x. [DOI] [PubMed] [Google Scholar]
  • 74.Rossi S L, Ross T M, Evans J D. West Nile virus. Clin Lab Med. 2010;30:47–65. doi: 10.1016/j.cll.2009.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Komar N, Clark G G. West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud Publica. 2006;19:112–117. doi: 10.1590/S1020-49892006000200006. [DOI] [PubMed] [Google Scholar]
  • 76.Lanciotti R S, Ebel G D, Deubel V, et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology. 2002;298:96–105. doi: 10.1006/viro.2002.1449. [DOI] [PubMed] [Google Scholar]
  • 77.Murray K, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect. 2006;134:1325–1332. doi: 10.1017/S0950268806006339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Diamond M S, Shrestha B, Marri A, et al. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003;77:2578–2586. doi: 10.1128/JVI.77.4.2578-2586.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Sitati E M, Diamond M S. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol. 2006;80:12060–12069. doi: 10.1128/JVI.01650-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Shrestha B, Diamond M S. Role of CD8+ T cells in control of West Nile virus infection. J Virol. 2004;78:8312–8321. doi: 10.1128/JVI.78.15.8312-8321.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Brien J D, Uhrlaub J L, Hirsch A, et al. Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med. 2009;206:2735–2745. doi: 10.1084/jem.20090222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Croft D R, Sotir M J, Williams C J, et al. Occupational risks during a monkeypox outbreak, Wisconsin, 2003. Emerg Infect Dis. 2007;13:1150–1157. doi: 10.3201/eid1308.061365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Huhn G D, Chase R A, Dworkin M S. Monkeypox in the Western hemisphere. N Engl J Med. 2004;350:1790–1791. doi: 10.1056/NEJMc040476. [DOI] [PubMed] [Google Scholar]
  • 84.Fenner F. Mousepox (infectious ectromelia): past, present, and future. Lab Anim Sci. 1981;31:553–559. [PubMed] [Google Scholar]
  • 85.Fang M, Cheng H, Dai Z, et al. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host. Virology. 2006;345:231–243. doi: 10.1016/j.virol.2005.09.056. [DOI] [PubMed] [Google Scholar]
  • 86.Karupiah G, Buller R M, Van Rooijen N, et al. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol. 1996;70:8301–8309. doi: 10.1128/jvi.70.12.8301-8309.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Fang M, Lanier L L, Sigal L J. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 2008;4:e30. doi: 10.1371/journal.ppat.0040030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Fang M, Sigal L J. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J Immunol. 2005;175:6829–6836. doi: 10.4049/jimmunol.175.10.6829. [DOI] [PubMed] [Google Scholar]
  • 89.Parker A K, Parker S, Yokoyama W M, et al. Induction of natural killer cell responses by ectromelia virus controls infection. J Virol. 2007;81:4070–4079. doi: 10.1128/JVI.02061-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Fang M, Sigal L J. Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host. J Immunol. 2006;177:8027–8036. doi: 10.4049/jimmunol.177.11.8027. [DOI] [PubMed] [Google Scholar]
  • 91.Fang M, Orr M T, Spee P, et al. CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity. 2011;34:579–589. doi: 10.1016/j.immuni.2011.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Fang M, Roscoe F, Sigal L J. Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking. J Exp Med. 2010;207:2369–2381. doi: 10.1084/jem.20100282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Xu R H, Fang M, Klein-Szanto A, et al. Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection. Proc Natl Acad Sci USA. 2007;104:10992–10997. doi: 10.1073/pnas.0701822104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Kastenmuller W, Torabi-Parizi P, Subramanian N, et al. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell. 2012;150:1235–1248. doi: 10.1016/j.cell.2012.07.021. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Science China. Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES